PHAT

PHAT Cost of Revenue

$40.93MTTM · USD

Period ending:

PHAT FY Cost of RevenueUSD
PHAT FY Cost of Revenue2018-12-31: $0.002019-12-31: $8.00K2020-12-31: $300.00K2021-12-31: $521.00K2022-12-31: $620.00K2023-12-31: $167.00K2024-12-31: $7.97M2025-12-31: $22.60M$22.60M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PHAT cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Phathom Pharmaceuticals Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
22,599,000
7,973,000
167,000
620,000
521,000
300,000
8,000
0

Compare cost of revenue

All PHAT financial metrics · PHAT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.